2 unknown, 1 completed, 1 recruiting. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Unknown 2, Completed 1, Recruiting 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow Ablation: new trials by email Literature Review of Ablation trials Research Report on Ablation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer 177Lu-PSMA-617, Ablation, Trans-arterial chemoembolization (TACE) - Metastatic Prostate Cancer, Prostate Cancer | Phase 1 | Recruiting | University of California, San Francisco | 30 | 2026-03-16 | 2026-11-12 |
| Ablation in Combination With Lenvatinib and Anti-PD-1 Antibodies lenvatinib + anti-PD-1 antibodies, ablation - Hepatocellular Carcinoma | Phase 1 | Unknown | Hua Li | 70 | 2024-01-01 | 2024-07-24 |
| Ablation Combined With PD-1 in HCC: Phase II Study PD-1 monoclonal antibody, Radiofequencey or microwave ablation - Hepatocellular Carcinoma | Phase 1 / Phase 2 | Unknown | Sun Yat-sen University | 30 | 2020-12-15 | 2023-04-19 |
| Magnetic Resonance-Guided High Intensity Focused Ultrasound for Palliation of Painful Skeletal Metastases Philips MR-guided HIFU system - Bone Metastasis | Phase 1 / Phase 2 | Completed | Philips Healthcare | 10 | 2011-01-01 | 2012-08-29 |
Carcinoma, Hepatocellular (2) · Prostatic Neoplasms (1)
Hua Li (1) · Philips Healthcare (1) · Sun Yat-sen University (1) · University of California, San Francisco (1)
China (2) · Canada (1) · United States (1)
Greg Czarnota, M.D. (1) · Rahul Aggarwal, MD (1)